Biotech Startups
9,862 companies tagged Biotech, with their investors and founders.
3 investors
MediBeacon develops biocompatible fluorescent tracer agents detected by skin sensors for clinical diagnostic applications including kidney function assessment and gastrointestinal permeability measurement. The company's medical technology platform serves clinicians managing patients with kidney disease and inflammatory bowel disorders, with additional applications in surgical visualization and preclinical research.
3 investors
Meiogenix develops a proprietary recombination technology that targets meiotic recombination to accelerate genetic gain and variety development in crops. It serves plant breeders through crop innovation partnerships and large-scale technology licensing, working on both specialty crops (tomato, fruits, vegetables) and field crops (corn, rice, wheat, soybean).
3 investors
Advancing gene and cell therapy delivery systems to address precision targeting challenges in living patients.
3 investors
Melio develops a rapid bloodborne pathogen testing platform that identifies common pathogens from blood samples within hours, replacing traditional multi-day culture-based diagnostics.
3 investors
MeMed develops diagnostic tests that decode the host immune response to differentiate bacterial from viral infections in emergency settings. The company provides rapid immunoassay-based diagnostic tools for clinicians to improve patient outcomes and antibiotic stewardship.
3 investors
RarePath is a biotech platform that creates pathways for scientists to develop cures for rare and ultra-rare diseases by partnering with academic researchers, biotech firms, and patient foundations to fund, license, and commercialize therapies.
3 investors
Merge Labs is a research lab developing brain-computer interfaces that connect with neurons using molecules instead of electrodes and non-invasive modalities like ultrasound, integrated with AI. It aims initially to help patients with injury or disease and later to broadly advance human capability.
3 investors
Mesentech develops prostaglandin prodrugs aimed at musculoskeletal regeneration. The company operates in the biotechnology and drug development space.
3 investors
Metagenomi Therapeutics is an in vivo genome editing company that uses genetic material sourced from natural environments (metagenomics) to develop a toolbox of editing tools for deletion, integration, and correction of genetic mutations. It focuses on developing genetic medicines to treat diseases with well-understood biology.
3 investors
Metri is a biotech company developing first-in-class, disease-modifying therapeutics for endometriosis and other uterine diseases originating in the endometrium. It is building a platform to identify reliable disease targets for conditions that currently lack targeted treatments.
3 investors
MiCAN Technologies produces immortalized blood cells (erythroid and myeloid-lineage cells) using regenerative medicine technology, supplying research-use blood-like cells, evaluation kits, and contract testing services. Its products serve infectious disease research and the efficacy/safety evaluation of pharmaceuticals and functional materials, including a pyrogen (fever-inducing substance) alternative testing kit.
3 investors
Micropep develops natural crop protection solutions using micropeptides—short protein molecules that regulate plant genes and proteins—for farmers seeking sustainable alternatives. The French-founded agricultural biotech company operates globally with expansion into the USA.
3 investors
Micrographia Bio pairs imaging mass spectrometry with AI analysis to map how proteins are distributed across tissue samples at cellular resolution. Drug developers use the resulting spatial proteomics data to identify potential therapeutic targets and study mechanisms of action.
3 investors
MicroMGx runs a high-throughput natural product discovery process that combines metabolomics and genomics (metabologenomics) to find bioactive compounds produced by microbes, supplying patented natural products to life science R&D organizations. Its portfolio includes a novel-mode-of-action herbicide and an anti-parasitic anthelmintic candidate for use in crops, livestock, pets, and humans.
3 investors
miRecule is a biotechnology company developing therapeutics, with programs focused on oncology. It applies RNA-based drug development approaches within the biotech industry.
3 investors
Mironid is a drug development company building a pipeline of therapies targeting cAMP-degrading phosphodiesterase enzymes to treat Autosomal Dominant Polycystic Kidney Disease (ADPKD) and other rare kidney diseases. It focuses on developing novel therapeutics for rare diseases with high unmet clinical need.
3 investors
Miruku develops dairy proteins produced from oilseed crops, targeting the food and beverage industry. The company combines plant biotechnology with dairy science to create sustainable alternatives to traditional dairy.
3 investors
Mirvie develops an RNA-based platform for early detection of pregnancy complications, enabling proactive intervention before complications become critical. The platform serves pregnant women and their healthcare providers to improve maternal and fetal health outcomes.
3 investors
Mitra develops a non-invasive skin diagnostics platform that combines clinical trials, skin sampling, next-generation sequencing, and data science to guide the design of age-rejuvenating skincare compounds. The company applies genomics to skin health and precision dermatological therapies.
3 investors
MOA Food Tech develops sustainable food ingredients. The company is focused on producing alternative ingredients for the food industry.
3 investors
Modern Synthesis is a biotechnology company that grows microbially-derived biomaterials from bacterial nanocellulose to replace animal leather and plastic-based synthetic textiles. It serves fashion and luxury brands, combining biology, material science, engineering, and textile craft to produce lower-impact materials.
3 investors
Modicus Prime provides an AI Management System (AIMS) for pharmaceutical companies and contract development and manufacturing organizations (CDMOs) to validate, audit, and govern AI systems across their operations in compliance with FDA and other regulatory requirements.
3 investors
3 investors